COVID-19
Top Ten most popular articles on Pharmafile.com this week
July 31, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Roche, UK government, Vaccine, lilly, pharma, top 10
Another week dominated by COVID-19. Among our most popular stories this week, Celltrion’s infliximab biosimilar Remsima has scored approval for …
Japan reserves 120m doses of BioNTech’s COVID-19 vaccine
July 31, 2020Manufacturing and Production, Medical Communications BioNTech, COVID-19, Japan, Vaccine, pharma
Japan’s Ministry of Health, Labour and Welfare (MHLW) has sealed a deal with Pfizer and BioNTech to secure 120 million …
Pharmafile.com’s weekly COVID-19 news round-up
July 29, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus, pharma
The once-touted COVID cure hydroxychloroquine continues its downward spiral of credibility as new data is published on its lack of …
UK Government secures 60 million doses of Sanofi and GSK’s COVID-19 vaccine
July 29, 2020Research and Development, Sales and Marketing COVID-19, GSK, Sanofi, UK government, pharma
The UK Government has sealed another deal to procure an effective COVID-19 vaccine for its citizens, partnering up with Sanofi …
Roche’s Actemra fails to improve clinical status in COVID-19-associated pneumonia
July 29, 2020Research and Development Actemra, COVID-19, Roche, pharma
Roche has announced the disappointing news that its therapy Actemra/RoActemra (tocilizumab) failed to improve clinical status to a statistically significant …
Yale-backed study to test efficacy of AI-selected therapy in COVID-19
July 28, 2020Manufacturing and Production, Research and Development AI, COVID-19, clinical trial, pharma
Biopharma firm AI Therapeutics is partnering with Yale School of Medicine to launch a new clinical trial to identify the efficacy …
US Government invests a further $472 million in Moderna’s BARDA-backed COVID-19 vaccine
July 27, 2020Research and Development, Sales and Marketing COVID-19, Moderna, US government, Vaccine
Moderna has revealed a second investment of $472 million from the US Government’s Biomedical Advanced Research and Development Authority (BARDA) to support …
India’s National Task Force rejects Biocon’s itolizumab for COVID-19
July 27, 2020Sales and Marketing Biocon, COVID-19, India, Itolizumab
Biocon was hit with bad news over the weekend as the National Task Force for COVID-19 in its home country …
Glenmark’s favipiravir accelerates viral clearance and clinical recovery in COVID-19 patients
July 24, 2020Medical Communications, Research and Development COVID-19, coronavirus, favipiravir; Glenmark
The antiviral treatment favipiravir, in development from Glenmark Pharma, has shown promise as a potential COVID-19 therapy after hitting its …
Brazilian study finds hydroxychloroquine is not effective at treating COVID-19
July 24, 2020Medical Communications COVID-19, coronavirus, hydroxychloroquine, pandemic
Another study has shown hydroxychloroquine is ineffective in treating the coronavirus. The research was published in the New England Journal …
Top Ten most popular articles on Pharmafile.com this week
July 24, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus, top 10, top 10 stories
As the coronavirus pandemic shows no signs of slowing down, an Israeli doctor has appeared to have contracted COVID-19 for …
UK Government invests £100m in new COVID-19 vaccine manufacturing site
July 23, 2020Manufacturing and Production, Research and Development COVID-19, UK, Vaccine, coronavirus
The UK Government’s Department for Business, Energy & Industrial Strategy has revealed a new pledge of an additional £100 million …
Research suggests COVID-19 outcomes are worse in colder months
July 23, 2020Research and Development COVID-19, coronavirus
A partnership between Chinese and European researchers has argued that the severity of COVID-19 could be worse in colder weather …
British pandemic strategy has been an “astonishing” failure, says cross-party parliamentary committee
July 23, 2020Business Services COVID-19, coronavirus, pandemic
There was an “astonishing” failure of the British government to plan for the economic fallout of a potential pandemic, according …
Pfizer and BioNTech’s COVID-19 vaccine shows promise in another early stage study
July 22, 2020Research and Development BioNTech, COVID-19, Pfizer, Vaccine, pharma
BioNTech and Pfizer have revealed more promising early data on their lipid nanoparticle formulated, nucleoside-modified messenger RNA vaccine candidate against …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
